Description
P-Alaxin Tablets contain dihydroartemisinin and piperaquine phosphate, making them effective as an artemisinin-based combination therapy (ACT) for treating uncomplicated malaria, particularly Plasmodium falciparum infections. Dihydroartemisinin works rapidly to reduce the malaria parasite load, while piperaquine sustains antimalarial effects, helping to prevent recurrence. P-Alaxin is typically taken over a three-day course, with dosing based on weight and specific medical guidance. This combination therapy is designed to improve treatment outcomes and reduce the risk of resistance, ensuring fast and sustained parasite clearance.
